rethinkTHC Search
Menu
Study breakdown

Not All High-THC Cannabis Extracts Are Equal for Cancer or Inflammation

ObservationalPreliminary evidence
The takeaway

Testing 25 high-THC cannabis extracts found wide variation in anti-cancer and anti-inflammatory effects, with specific terpenes like terpinene and p-cymene correlating with better outcomes.

Medical cannabis researchers, people interested in the entourage effect

66% to 92% range in cancer growth inhibition across extracts

What the researchers found

Anti-cancer efficacy ranged from 66% to 92% growth inhibition across 25 extracts. For inflammation, some extracts reduced cytokine expression by over 5-fold while others doubled it. The terpene terpinene correlated with anti-cancer activity (P=0.002), and p-cymene and beta-myrcene correlated with anti-inflammatory effects.

Why it matters

This study demonstrates that the "entourage effect" is real and measurable: cannabis extracts with similar THC levels produce vastly different biological outcomes depending on their terpene profiles.

The numbers in context

25 extracts tested; 66-92% cancer growth inhibition range; >5-fold inflammation reduction (best) to 2-fold increase (worst); terpinene P=0.002 for anti-cancer

How the study worked

In vitro testing of 25 high-THC cannabis extracts on squamous cell carcinoma (HCC1806) cells and TNF-alpha/IFN-gamma-induced inflammation in human lung fibroblasts (WI38). Chemical profiling of THC, CBD, CBG, CBN, and 20 terpenes with correlation analysis.

What this study cannot tell us

In vitro study only. Cancer cell line results do not predict clinical outcomes. Correlation between terpenes and activity does not prove the terpenes are directly responsible.

How to read the evidence

In vitro study on cell lines with correlational terpene analysis. No animal or human data.

When this study was published

Published in 2022

The bigger picture

Not all cannabis is created equal. The specific combination of terpenes may matter as much as the THC content for medicinal effects, supporting the move toward terpene-aware product labeling.

Questions still open

  • Would terpene-enriched extracts show enhanced anti-cancer effects in animal models? Could terpene profiles be used to predict which cannabis products are most anti-inflammatory versus pro-inflammatory?

Common questions

Do all cannabis extracts fight cancer equally?
No. This study found cancer growth inhibition ranged from 66% to 92% across 25 high-THC extracts, and some extracts actually worsened inflammation rather than reducing it.
Which terpenes were linked to anti-cancer effects?
Terpinene showed the strongest correlation with anti-cancer activity (P=0.002). For anti-inflammatory effects, p-cymene and beta-myrcene were positively correlated, while camphor was negatively correlated.

Read the original research

Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts.

Molecules (Basel, Switzerland), 27(18)

Citation

Li, Dongping; Ilnytskyy, Yaroslav; Ghasemi Gojani, Esmaeel; Kovalchuk, Olga; Kovalchuk, Igor. (2022). Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts.. Molecules (Basel, Switzerland), 27(18). https://doi.org/10.3390/molecules27186057

Explore the wider topic